Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 5:18:1365598.
doi: 10.3389/fnins.2024.1365598. eCollection 2024.

Understanding the mechanism of acupuncture in acute cerebral infraction through a proteomic analysis: protocol for a prospective randomized controlled trial

Jiangpeng Cao #  1   2   3 , Yuanhao Du  1   3 , Xiumei Yin  1   2   3 , Na Zheng  4 , Jiawei Han  5 , Linling Chen  6 , Lanyu Jia  7
Affiliations

Understanding the mechanism of acupuncture in acute cerebral infraction through a proteomic analysis: protocol for a prospective randomized controlled trial

Jiangpeng Cao et al. Front Neurosci. .

Abstract

Background: Acute cerebral infarction (ACI), being the predominant form of stroke, presents challenges in terms of the limited effectiveness of various treatments in improving the neurological function. Although acupuncture shows promise in addressing ACI, the availability of high-quality evidence regarding its efficacy, safety, and underlying mechanism remains insufficient. In this study, we design a multicenter, prospective, single-blind, randomized controlled trial with the aim of evaluating the efficacy and safety of acupuncture for ACI, making an attempt to unveil the molecular mechanisms by proteomic.

Methods: A total of 132 patients involving four hospitals will be randomized at a 1:1:1 ratio in the acupuncture group, control group, and sham acupuncture group. All the patients will receive basic treatment, and the patients in the acupuncture and sham acupuncture groups will also receive either acupuncture or sham acupuncture treatment, respectively, at six sessions each week for a 2 weeks period, followed by 3 months of follow-up. The primary outcome will be the change in the National Institute of Health Stroke Scale (NIHSS) scores after treatment. The secondary outcomes will include the Fugl-Meyer Assessment (FMA) scale scores and the Barthel Index (BI). Adverse events that occur during the trial will be documented. To discover differentially expressed proteins (DEPs) and their roles between the ACI subjects and healthy controls, we will also perform 4D-DIA quantitative proteomics analysis, and the DEPs will be confirmed by enzyme-linked immunosorbent assay (ELISA). This study was approved by the institutional review board of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (TYLL2023043). Written informed consent from patients is required. This trial is registered in the Chinese Clinical Trial Registry (ChiCTR2300079204). Trial results will be published in a peer-reviewed academic journal.

Discussion: The results of this study will determine the preliminary efficacy and safety of acupuncture in ACI patients and whether the mechanism of this form of non-pharmacologic stimulation is mediated by a novel therapeutic target for neurorehabilitation through our proteomic analysis.

Clinical trial registration: https://www.chictr.org.cn, identifier ChiCTR2300079204.

Keywords: acupuncture; acute cerebral infraction; proteomic analysis; protocol; randomized controlled trial.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
A flowchart of the study.
Figure 2
Figure 2
Study design and workflow. AG, acupuncture group; HG, health group; DDA, data-dependent acquisition; DIA, data-independent acquisition.
See this image and copyright information in PMC

References

    1. Atkinson A. J., Colburn W. A., DeGruttola A. G., DeMets D. L., Downing G. J., Hoth J. F., et al. . (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Therapeutics 69, 89–95. doi: 10.1067/mcp.2001.113989, PMID: - DOI - PubMed
    1. Cao B. Q., Tan F., Zhan J., Lai P. H. (2021). Mechanism underlying treatment of ischemic stroke using acupuncture: transmission and regulation. Neural Regen. Res. 16, 944–954. doi: 10.4103/1673-5374.297061, PMID: - DOI - PMC - PubMed
    1. Chamorro Á., Dirnagl U., Urra X., Planas A. M. (2016). Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 15, 869–881. doi: 10.1016/S1474-4422(16)00114-9 - DOI - PubMed
    1. Chinese Society of Neurology, & Chinese Stroke Society (2018). Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018. Chin. J. Neurol. 51:e4. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004 - DOI
    1. Costa V., Angelini C., de Feis I., Ciccodicola A. (2010). Uncovering the complexity of transcriptomes with RNA-Seq. J. Biomed. Biotechnol. 2010, 1–19. doi: 10.1155/2010/853916, PMID: - DOI - PMC - PubMed

LinkOut - more resources